Oncology PracticeNivo + ipi shows durable activity against metastatic melanomaOctober 31, 2018Immuno-oncologyMelanoma
Oncology PracticeCheckpoint inhibitor doubles 3-year survival rate of BRAF wild-type advanced melanomaOctober 25, 2018Immuno-oncologyMelanoma
Oncology PracticeTKIs and immunotherapy hold promise for alveolar soft part sarcomaOctober 23, 2018Sarcoma & GISTRare SarcomasImmuno-oncology
Oncology PracticeCheckpoint inhibitor seems safe and effective for patients with HIVOctober 23, 2018Immuno-oncologyMelanomaLung Cancer
Oncology PracticeCheckpoint inhibitor/TKI combo improves PFS of RCC over sunitinibOctober 22, 2018Renal Cell CarcinomaGenitourinary CancerImmuno-oncology
Oncology PracticeFinally, immunotherapy shows benefit in TNBCOctober 21, 2018Breast CancerImmuno-oncology
Hematology NewsKymriah appears cost effective in analysisOctober 17, 2018ALLImmuno-oncologyPediatricsPractice ManagementBusiness of Medicine
Hematology NewsResearchers consider R/R ALL drugs in the first-line settingOctober 17, 2018ALLLeukemia, Myelodysplasia, TransplantationImmuno-oncology
Hematology NewsIbrutinib plus obinutuzumab gets priority review in CLL/SLLOctober 17, 2018CLLIndolent LymphomaLeukemia, Myelodysplasia, TransplantationImmuno-oncology
Oncology PracticeDETERRED trial: Concurrent atezolizumab, CRT shows promise in LA-NSCLCOctober 15, 2018Lung CancerImmuno-oncology
Oncology PracticeEpacadostat plus pembrolizumab shows promise in advanced solid tumorsOctober 5, 2018Immuno-oncologyMelanomaRenal Cell CarcinomaLung CancerHead & Neck/Thyroid CancersGynecologic Cancer
Hematology NewsB-cell maturation antigen targeted in myeloma trialsOctober 2, 2018Immuno-oncologyMultiple MyelomaLymphoma & Plasma Cell Disorders
Oncology PracticeIMpower133: Atezolizumab plus standard chemotherapy boosted survival in ES-SCLCOctober 2, 2018Lung CancerImmuno-oncology
Oncology PracticeCheckpoint inhibitor linked to antiphospholipid syndrome in melanoma patientOctober 2, 2018Immuno-oncologyMelanomaPatient & Survivor Care
Hematology NewsFirst reported case of induced resistance to tisagenlecleucelOctober 1, 2018ALLCellular TherapyLeukemia, Myelodysplasia, TransplantationImmuno-oncology
